NASP Controls Histone Turnover Behind PARP Resistance
The emergence of poly(ADP-ribose) polymerase inhibitors (PARPi) as a transformative therapy for homologous recombination-deficient tumors has significantly altered the landscape ...
The emergence of poly(ADP-ribose) polymerase inhibitors (PARPi) as a transformative therapy for homologous recombination-deficient tumors has significantly altered the landscape ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine